$40.42
-0.34 (-0.83%)
Performance
1D
—
1W
—
1M
—
3M
+10.05%
6M
-4.56%
1Y
+36.05%
YTD
-4.65%
Open$40.76
Previous Close$40.76
Day High$41.03
Day Low$38.71
52W High$50.71
52W Low$22.61
Volume—
Avg Volume1.10M
Market Cap3.15B
P/E Ratio47.40
EPS$0.81
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$40.85
Below
SMA 200
$34.09
Above
RSI (14)
37.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
+15.9% upside
Current
$40.42
$40.42
Target
$46.85
$46.85
$30.44
$46.85 avg
$57.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 499.46M | 414.94M | 507.99M |
| Net Income | 64.08M | 47.91M | -2,027,984 |
| Profit Margin | 12.8% | 12.2% | -0.4% |
| EBITDA | 57.38M | 45.29M | -2,983,128 |
| Free Cash Flow | — | — | -1,866,923 |
| Rev Growth | +20.4% | +20.4% | +16.6% |
| Debt/Equity | — | — | 0.52 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |